FDA 21 CFR Part 11 Compliance in Life Sciences for 2025
In 2025, the life sciences industry continues to advance at a remarkable pace, driven largely by digital transformation.
GMP compliance in life sciences with next-gen tech
Life sciences companies face mounting pressure to meet stringent FDA and EMA manufacturing standards without compromising compliance. Next-gen tech in the form of B2B SaaS compliance solutions is helping pharmaceutical companies to maintain regulatory approval and make strategic advancements.
Regulatory Wrap Episode 71: FDA takes aim at pharma companies’ social media activity
In Regulatory Wrap for the week to October 3, Ryan Thaxton explores the growing spotlight on pharma companies’ social media activity.
Pharma compliance solutions and regulatory success
The pharmaceutical industry operates under some of the strictest oversight in the business world, where a single misstep can cost millions and derail years of research. Consequently, robust pharma compliance solutions are fundamental to ensuring regulatory success and achieving operational efficiency.
FDA takes aim at pharmaceuticals’ social media activity
The FDA is turning its eye towards pharmaceuticals’ social media use. Review the laws and regulations triggering FDA warning letters and how to stay compliant.